亲爱的研友该休息了!由于当前在线用户较少,发布求助请尽量完整地填写文献信息,科研通机器人24小时在线,伴您度过漫漫科研夜!身体可是革命的本钱,早点休息,好梦!

Overt Thyroid Dysfunction and Anti-Thyroid Antibodies Predict Response to Anti-PD-1 Immunotherapy in Cancer Patients.

甲状腺癌 抗体 自身抗体 免疫疗法 肿瘤科 甲状腺炎 甲状腺球蛋白 甲状腺癌
作者
Edwin A. Basak,Jan van der Meer,Daan P. Hurkmans,Marco W.J. Schreurs,Esther Oomen-de Hoop,Astrid A M van der Veldt,Sander Bins,Arjen Joosse,Stijn L.W. Koolen,Reno Debets,Robin P. Peeters,Joachim G.J.V. Aerts,Ron H.J. Mathijssen,Marco Medici
出处
期刊:Thyroid [Mary Ann Liebert, Inc.]
卷期号:30 (7): 966-973 被引量:18
标识
DOI:10.1089/thy.2019.0726
摘要

Background: Thyroid dysfunction is among the most common adverse effects during anti-programmed cell death 1 (PD-1) immunotherapy, and alongside correlations with elevated anti-thyroid antibodies (ATAb), studies have found correlations with survival. However, the exact relations remain to be clarified. We, therefore, aimed at clarifying the relationship between thyroid dysfunction, ATAbs, and survival in anti-PD-1 treated cancer patients. Methods: We included 168 patients with nonsmall-cell lung carcinoma, renal cell carcinoma, and metastatic melanoma treated with nivolumab or pembrolizumab. Thyrotropin and free T4 (fT4) levels were measured before each anti-PD-1 infusion. ATAb levels (anti-thyroid peroxidase [TPO] and anti-thyroglobulin [Tg]) were measured at baseline and after two months of treatment. Although the vast majority of patients had detectable levels of ATABs, only a few patients had positive ATAbs when using conventional cut-offs. To study the consequences of detectable ATABs, the cut-off levels were a priori set at the median concentrations at baseline in the study population. Tumor progression was classified according to RECIST v1.1. Results: Patients who acquired overt thyroid dysfunction during treatment had significantly higher overall survival (OS) (hazard ratio [HR] = 0.18 confidence interval [CI: 0.04-0.76]; p = 0.020) and progression-free survival (PFS) (HR = 0.39 [0.15-0.998]; p = 0.050) than patients without thyroid dysfunction with 1-year OS rates of 94% vs. 59% and 1-year PFS rates of 64% vs. 34%. During treatment, patients with ATAb levels above the median had a higher OS (HR = 0.39 [0.21-0.72]; p = 0.003) and PFS (HR = 0.52 [0.33-0.81]; p = 0.004) than patients with ATAb levels below the median, with 1-year OS rates of 83% vs. 49% and PFS rates of 54% vs. 20%, respectively. When analyzing ATAb levels over time, patients with a persistent ATAb level above the median had a higher OS (HR = 0.41 [0.19-0.89], p = 0.025) and PFS (HR = 0.54 [0.31-0.95], p = 0.032) compared with patients with a persistent ATAb level below the median. Patients whose ATAb levels increased above the median during treatment had an improved OS (HR = 0.27 [0.06-1.22], p = 0.088) and PFS (HR = 0.24 [0.07-0.77], p = 0.017) compared with patients whose ATAb levels decreased below the median. Conclusions: Acquired overt thyroid toxicity and above median ATAb levels during anti-PD-1 treatment are associated with improved PFS and OS. In addition, our results suggest that ATAb levels at baseline are of clinical relevance for PFS and OS.

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
时尚的映容完成签到,获得积分10
1秒前
UNIQUE完成签到 ,获得积分10
2秒前
闪闪的妖妖完成签到,获得积分10
6秒前
完美的睿渊完成签到,获得积分10
6秒前
乐康完成签到,获得积分10
8秒前
9秒前
14秒前
14秒前
书进1113完成签到,获得积分10
16秒前
米龙完成签到,获得积分10
18秒前
我是老大的应助被追寻从寒采纳,获得10
22秒前
qty完成签到 ,获得积分10
23秒前
lhh发布了新的文献求助10
23秒前
顺心醉柳完成签到 ,获得积分10
23秒前
24秒前
26秒前
30秒前
甜美幻露发布了新的文献求助30
32秒前
广州小肥羊完成签到 ,获得积分10
32秒前
ping发布了新的文献求助30
33秒前
33秒前
34秒前
GingerF的应助被OK采纳,获得100
35秒前
小蘑菇的应助被一期一会采纳,获得10
36秒前
Lu完成签到,获得积分10
37秒前
38秒前
wang完成签到 ,获得积分10
39秒前
42秒前
43秒前
研友_VZG7GZ的应助被小花采纳,获得10
43秒前
44秒前
44秒前
学学半完成签到 ,获得积分10
45秒前
科研通AI6.3的应助被甜美幻露采纳,获得10
48秒前
情怀的应助被科研通管家采纳,获得10
48秒前
一期一会发布了新的文献求助10
48秒前
我是老大的应助被科研通管家采纳,获得10
48秒前
孤独的神完成签到 ,获得积分10
49秒前
大模型的应助被科研通管家采纳,获得10
49秒前
秋风的应助被科研通管家采纳,获得10
49秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 2000
Handbook of Sport Coaching Research 1000
Orthognathic Surgery - 2 Volume Set 500
高分子基功能界面水蒸发材料与应用研究 500
外场增强的水汽发电研究 500
基于结构调控的功能化水诱导发电材料与器件研究 500
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8195022
求助须知:如何正确求助?哪些是违规求助? 9580753
关于积分的说明 21872568
捐赠科研通 7794759
什么是DOI,文献DOI怎么找? 3437852
关于科研通互助平台的介绍 2561176
邀请新用户注册赠送积分活动 2484546